US81727U1051 - Common Stock
Senseonics Holdings (SENS) stock fell 9% despite a Q4 beat as analysts pointed to concerns over demand for its Eversense glucose monitoring device. Read more here.
Senseonics beats expectations with Q4 earnings as GAAP EPS comes in at -$0.03, surpassing estimates by $0.01.
Major earnings expected after the bell on Thursday include:Zscaler (ZS)Hewlett Packard Enterprise Company (HPE)Dell Technologies (DELL)Autodesk (ADSK)Veeva...
/PRNewswire/ -- Ascensia Diabetes Care, a global diabetes care company, and Senseonics Holdings, Inc. (NYSE American: SENS), a medical technology company...
Make sure you have your sights set on these penny stocks to watch. Each has a strong upside and positive growth prospects for the future.
Senseonics Holdings expects to report revenues of $8 million for Q4 2023 and $22 million for full year 2023, with cash balance of $109.8 million.
Medical technology company Senseonics (SENS) entered into a $50M loan facility with Hercules Capital
Medical device company Senseonics (SENS) on Thursday swung to a quarterly loss and missed on revenue expectations. Read more here.
Senseonics press release (SENS): Q2 GAAP EPS of -$0.04 in-line.Revenue of $4.13M (+11.6% Y/Y) misses by $0.36M.U.S. revenue was $1.8 million in the second quarter of 2023 compared...
Investors have the rare chance to get in on these millionaire-maker penny stocks that have massive potential in small-cap names.